Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Bioceres Crop Solutions Corp (BIOX)

27 + Investors. Track Smart Money conviction in BIOX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -3
Streak
2Q ▼
Buyers last Q
42%

Smart Money Signals — BIOX

Based on 28 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their BIOX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 54% of 3.0Y high

54% of all-time peak
Only 28 funds hold BIOX today versus a peak of 52 funds at 2024 Q1 — just 54% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 26% fewer funds vs a year ago

fund count last 6Q
10 fewer hedge funds hold BIOX compared to a year ago (-26% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 42% buying

11 buying15 selling
Last quarter: 15 funds reduced or exited vs 11 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~4 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 10 → 10 → 4 → 4. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

75% of holders stayed for 2+ years

■ 75% conviction (2yr+) ■ 11% medium ■ 14% new
21 out of 28 hedge funds have held BIOX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -7%, value -27%

Value
-26%
Shares
-6%
Last quarter: funds added -7% more shares while total portfolio value only changed -27%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
⚠️

Saturation — most institutions already know this story

6 → 10 → 10 → 4 → 4 new funds/Q
New funds entering each quarter: 10 → 10 → 4 → 4. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
🏛️

Veteran-anchored — 67% veterans vs 17% newcomers

■ 67% veterans ■ 17% 1-2yr ■ 17% new
Entry-cohort mix of 30 holders: 20 (67%) are 2+ year veterans, 5 entered 1–2 years ago, and 5 (17%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 9% AUM from top-100

9% from top-100 AUM funds
10 of 27 holders rank in the top 100 by AUM, but together hold only 9% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
1.5
out of 10
Low Exit Risk
Exit risk score 1.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BIOX

In 2026 Q2, 11 hedge funds were net buyers of BIOX (4 opened a new position, 7 added to an existing one), while 15 reduced or exited (8 trimmed, 7 sold completely) — a 42% buyer ratio, indicating roughly balanced activity. Net selling has persisted for two consecutive quarters. Net fund flow last quarter: -3 funds (more exits than new entries). Total institutional holders: 28.

Hedge Fund Ownership: BIOX

How many hedge funds hold BIOX — quarterly history vs. share price
Quarterly hedge fund ownership of BIOX vs. share price

Market Analysis: BIOX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BIOX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

1 top-rated funds 0 high-conviction
Consensus
1.3
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: BIOX
2026 Q3 Stats Unlock in 48 days 27 + Investors

Track Smart Money conviction in BIOX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 27 31 -12.9%
13F Shares 9M 9M -6.77%
Total Value $3M $4M -26.6%
New Positions 4 4 -
Increased Positions 8 9 -1
Closed Positions 7 11 -4
Reduced Positions 6 5 +1
Total Calls 2 1 100.0%
Total Puts 1 0 100%
PUT/CALL Ratio 0.5 0.0 Bullish

Statistics: BIOX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

27 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BIOX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 BIOX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Solel Partners LP 0.27% 4,579,364 $1.6M
2 Ardsley Advisory Partners LP 0.02% 475,000 $166K
3 Long Focus Capital Management, LLC 0.01% 829,748 $290K
4 Ping Capital Management, INC. 0.00% 55,000 $19K
5 Ping Capital Management, INC. 0.00% 30,000 $11K
6 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% 1,406,223 $492K
7 MJT & Associates Financial Advisory Group, Inc. 0.00% 1,487 —
8 Tower Research Capital LLC (TRC) 0.00% 9,547 $3K
9 PNC Financial Services Group, INC. 0.00% 133,000 $47K
10 J.Safra Asset Management Corp 0.00% 1,400 —
11 UBS Group AG 0.00% 408,276 $143K
12 Stifel Financial Corp 0.00% 29,588 $10K
13 Two Sigma Investments, LP 0.00% 30,026 $11K
14 Group One Trading LLC 0.00% 15,257 $5K
15 Citadel Advisors LLC 0.00% 169,500 $59K
16 Susquehanna International Group, LLP 0.00% 212,930 $75K
17 EFG International AG 0.00% 750 —
18 Goldman Sachs Group Inc 0.00% 129,445 $45K
19 SBI Securities Co., Ltd. 0.00% 279 —
20 Harbour Investments, INC. 0.00% 352 —
21 Jane Street Group, LLC 0.00% 36,268 $13K
22 Osaic Holdings, INC. 0.00% 1,205 —
23 Citadel Advisors LLC 0.00% 11,600 $4K
24 Morgan Stanley 0.00% 18,014 $6K
25 Allworth Financial LP 0.00% 211 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Bioceres Crop Solutions Corp (BIOX)

What does the Smart Money Trend signal show for BIOX?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their BIOX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BIOX?

More sellers than buyers — 42% buying: Last quarter: 15 funds reduced or exited vs 11 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for BIOX holders?

Smaller funds dominant — 9% AUM from top-100: 10 of 27 holders rank in the top 100 by AUM, but together hold only 9% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held BIOX?

75% of holders stayed for 2+ years: 21 out of 28 hedge funds have held BIOX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →